| Entry |
|
|---|
| Name |
Eszopiclone (JAN/USAN/INN);
Estorra (TN);
Lunesta (TN)
|
|---|
| Product |
|
|---|
| Generic |
ESZOPICLONE (A-S Medication Solutions), ESZOPICLONE (A-S Medication Solutions), ESZOPICLONE (A-S Medication Solutions), ESZOPICLONE (A-S Medication Solutions), ESZOPICLONE (A-S Medication Solutions), ESZOPICLONE (A-S Medication Solutions), ESZOPICLONE (Aidarex Pharmaceuticals LLC), ESZOPICLONE (Aidarex Pharmaceuticals LLC), ESZOPICLONE (Aidarex Pharmaceuticals LLC), ESZOPICLONE (Aidarex Pharmaceuticals LLC), ESZOPICLONE (Aphena Pharma Solutions - Tennessee), ESZOPICLONE (Aphena Pharma Solutions - Tennessee), ESZOPICLONE (Aurobindo Pharma Limited), ESZOPICLONE (Bryant Ranch Prepack), ESZOPICLONE (Bryant Ranch Prepack), ESZOPICLONE (Bryant Ranch Prepack), ESZOPICLONE (Bryant Ranch Prepack), ESZOPICLONE (Bryant Ranch Prepack), ESZOPICLONE (Bryant Ranch Prepack), ESZOPICLONE (DIRECT RX), ESZOPICLONE (DIRECT RX), ESZOPICLONE (DIRECT RX), ESZOPICLONE (DIRECT RX), ESZOPICLONE (DIRECT RX), ESZOPICLONE (DIRECT RX), ESZOPICLONE (DIRECT RX), ESZOPICLONE (Direct Rx), ESZOPICLONE (DirectRX), ESZOPICLONE (DirectRX), ESZOPICLONE (Dr. Reddy's Laboratories Limited), ESZOPICLONE (Glenmark Pharmaceuticals Inc. USA), ESZOPICLONE (Golden State Medical Supply), ESZOPICLONE (Lake Erie Medical DBA Quality Care Products LLC), ESZOPICLONE (Lake Erie Medical DBA Quality Care Products LLC), ESZOPICLONE (Lake Erie Medical DBA Quality Care Products LLC), ESZOPICLONE (Lake Erie Medical DBA Quality Care Products LLC), ESZOPICLONE (Lake Erie Medical DBA Quality Care Products LLC), ESZOPICLONE (Lupin Pharmaceuticals), ESZOPICLONE (Macleods Pharmaceuticals Limited), ESZOPICLONE (Medsource Pharmaceuticals), ESZOPICLONE (Mylan Institutional), ESZOPICLONE (Mylan Pharmaceuticals), ESZOPICLONE (NuCare Pharmaceuticals), ESZOPICLONE (NuCarePharmaceuticals), ESZOPICLONE (OrchidPharma), ESZOPICLONE (PD-Rx Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Preferred Pharmaceuticals), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (Proficient Rx LP), ESZOPICLONE (REMEDYREPACK), ESZOPICLONE (REMEDYREPACK), ESZOPICLONE (REMEDYREPACK), ESZOPICLONE (REMEDYREPACK), ESZOPICLONE (St. Mary's Medical Park Pharmacy), ESZOPICLONE (Sun Pharmaceutical Industries), ESZOPICLONE (Teva Pharmaceuticals USA), ESZOPICLONE (Unit Dose Services), ESZOPICLONE (Unit Dose Services), ESZOPICLONE (Unit Dose Services), ESZOPICLONE (Unit Dose Services), ESZOPICLONE (Unit Dose Services), ESZOPICLONE (West-Ward Pharmaceuticals Corp.) |
|---|
| Formula |
C17H17ClN6O3
|
|---|
| Exact mass |
388.1051
|
|---|
| Mol weight |
388.8083
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Class |
Neuropsychiatric agent
DG01836 Non-benzodiazepine sedative-hypnotics
DG01567 GABA-A receptor agonist
Metabolizing enzyme substrate
DG02855 CYP2E1 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Therapeutic category: | 1129 |
|
|---|
| Efficacy |
Sedative-hypnotic |
|---|
| Disease |
|
|---|
| Comment |
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]; CYP2E1 [HSA: 1571]
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07230 | GABA-A receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CF Benzodiazepine related drugs
N05CF04 Eszopiclone
D02624 Eszopiclone (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Sleep Disorder Agents
GABA Receptor Modulators
Eszopiclone
D02624 Eszopiclone (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
112 Hypnotics and sedatives, anxiolytics
1129 Others
D02624 Eszopiclone (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D02624 Eszopiclone (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02624
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02624
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02624
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 27
1 C8x C 13.5800 -12.3200
2 C8x C 13.5800 -13.7200
3 N5x N 14.7700 -14.4200
4 C8y C 16.0300 -13.7200
5 C8y C 16.0300 -12.3200
6 N5x N 14.7700 -11.6200
7 C1y C 17.3600 -14.1400
8 N1y N 18.2000 -13.0200
9 C5x C 17.3600 -11.9000
10 C8y C 19.5300 -13.0200
11 N5x N 20.2300 -11.8300
12 C8x C 21.6300 -11.8300
13 C8y C 22.3300 -13.0200
14 C8x C 21.6300 -14.2100
15 C8x C 20.2300 -14.2100
16 O5x O 17.7800 -10.5700
17 X Cl 23.7300 -13.0200
18 O7a O 17.3600 -15.5400
19 C7a C 18.5500 -16.2400
20 N1y N 18.5500 -17.6400
21 O6a O 19.8100 -15.5400
22 C1x C 17.3600 -18.3400
23 C1x C 17.3600 -19.7400
24 N1y N 18.5500 -20.4400
25 C1x C 19.8100 -19.7400
26 C1x C 19.8100 -18.3400
27 C1a C 18.5500 -21.8400
BOND 30
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 5 9 1
11 8 10 1
12 10 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 14 15 2
17 10 15 1
18 9 16 2
19 13 17 1
20 18 19 1
21 19 20 1
22 19 21 2
23 7 18 1 #Up
24 20 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 20 26 1
30 24 27 1
|
|---|
|
